Why Dalmia Bharat shares jumped 11% intraday
Shares of Dalmia Bharat surged 11.15 per cent to hit 52-week high of Rs 1,690.60 on the BSE after the Supreme Court ordered restoration of mutual fund units to Dalmia Bharat Group
BusinessToday.In | March 17, 2021 | Updated 13:07 IST
Dalmia Bharat shares hit 52-week high
Shares of Dalmia Bharat rallied over 11 per cent in intraday trade, in an otherwise weak market, on the Bombay Stock Exchange on Wednesday after the Supreme Court ordered restoration of mutual fund units to Dalmia Bharat Group. The apex court on Tuesday directed IL&FS Securities Services (ISSL) to release mutual fund units worth Rs 344 crore to the Dalmia Bharat Group.
The company said on Tuesday that it expects to commence production of Sputnik V at its facilities in Hyderabad from the third quarter of 2021, with deliveries estimated to start from the fourth quarter of 2021.
HYDERABAD: Gland Pharma, based out of Hyderabad, has entered into an agreement with Russian Direct Investment Fund (RDIF), a sovereign wealth fund, to manufacture and supply 252 million (25.2 crore) doses of the Russian Covid-19 vaccine Sputnik V.
The company said on Tuesday that it expects to commence production of Sputnik V at its facilities in Hyderabad from the third quarter of 2021, with deliveries estimated to start from the fourth quarter of 2021.
This stock rallied 1,300% in 12 months; should you subscribe?
Shares of Intellect Design Arena has rallied 31 per cent over the last five sessions and 1,322 per cent in one year from its 52-week low of Rs 44, touched on March 25
Chitranjan Kumar | March 16, 2021 | Updated 16:34 IST
Intellect Design Arena share price surged 20% on Tuesday
Shares of Intellect Design Arena rallied 20 per cent in intraday trade to hit 52-week high of Rs 626 on Bombay Stock Exchange on Tuesday, in an otherwise lackluster market, on strong volume. The stock of Chennai-headquartered financial technology company has rallied 31 per cent over the last five sessions and 1,322 per cent in one year from its 52-week low of Rs 44, touched on March 25.
Stock Market News Update Today: Sensex and Nifty are set to open higher on Friday, tracking firm global cues and strong trading at Nifty futures on the Singapore Exchange
AstraZeneca Pharma share rises 2% on DCGI nod for cancer drug
AstraZeneca Pharma share gained as much as 1.88 per cent to hit a high of Rs 3,480 after the drug maker received import and market permission from the DCGI for osimertinib tablets (Tagrisso) used in treatment of non-small cell lung cancer
BusinessToday.In | March 12, 2021 | Updated 13:19 IST
AstraZeneca Pharma share jumps 2% to Rs 3,480
Share of AstraZeneca Pharma gained nearly 2 per cent in opening deals on Bombay Stock Exchange on Friday after the drug maker received import and market permission from the Drugs Controller General of India (DCGI) for osimertinib tablets (Tagrisso) used in treatment of non-small cell lung cancer. Meanwhile, Sensex was trading 349 points or 0.68 per cent higher at 51,628.